More on Aldeyra Q2 results

|About: Aldeyra Therapeutics, ... (ALDX)|By:, SA News Editor

Aldeyra Therapeutics (NASDAQ:ALDX) Q2 results: Revenue: $0; Operating Expenses: $1.6M; Operating Loss: ($1.6M) (-67.0%); Net Loss: ($5.3M) (-210.1%); Loss Per Share: ($1.56) (+71.5%); Quick Assets: $11.5M (+248.5%).

No guidance given.